Vivifi's Treatment, BPH Treatment Via Vasculature Anastomosis of the Internal Spermatic Vein and Ligation of the Deferential Vein
The study objective is to evaluate the safety and feasibility of the Vivifi's Treatment. The Vivifi's Treatment presents an innovative approach for addressing benign prostatic hyperplasia (BPH) as well as clinical/subclinical varicoceles in men. The scientific rationale for conducting this study is to assess the safety and feasibility of the Vivifi's Treatment (a surgical procedure) as a therapeutic intervention for patients with BPH.
• Male 40-75 years of age
• Diagnosed with Benign prostatic hyperplasia (BPH)
• Prostate volume: ≥ 30 ≤ 120 cc measured by transrectal ultrasound
• Signed the study informed consent form (ICF)
• Presence of Lower Urinary Tract Symptoms (LUTS) measured by International Prostate Symptoms Score (IPSS) greater than 12
• Presence of clinical varicocele (preferably grade II or III - Dubin \& Amelar.